发明名称 (2S,3R)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)BENZOFURAN-2-CARBOXAMIDE, NOVEL SALT FORMS, AND METHODS OF USE THEREOF
摘要 <p>Disclosed is (2S,3R) N-(2-((3-pyridinyl)methyl-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2- carboxamide, substantially free of (2S,3S), (2R,3S), or (2R,3R) isomers, or a pharmaceutically acceptable salt thereof for use in the treatment of mild cognitive impairment, age-associated memory impairment, pre-senile dementia, early onset Alzheimer's disease, senile dementia, dementia of the Alzheimer's type, Alzheimer's disease, Lewy Body dementia, micro- infarct dementia, AIDS-related dementia, HIV -dementia, multiple cerebral infarcts, Parkinsonism, Parkinson's disease, Pick's disease, progressive supranuclear palsy, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania, attention deficit disorder, attention deficit hyperactivity disorder, anxiety, depression, dyslexia, schizophrenia, cognitive dysfunction in schizophrenia, depression, obsessive-compulsive disorders, or Tourette's syndrome.</p>
申请公布号 NZ582986(A) 申请公布日期 2012.01.12
申请号 NZ20080582986 申请日期 2008.08.01
申请人 TARGACEPT, INC. 发明人 BENCHERIF, MEROUANE;BENSON, LISA;DULL, GARY MAURICE;GATTO, GREGORY J;GENUS, JOHN;JORDAN, KRISTEN G;MATHEW, JACOB;MAZUROV, ANATOLY A;MIAO, LAN;MUNOZ, JULIO A;PFEIFFER, INIGO;PFEIFFER, SONDRA;PHILLIPS, TERESA Y
分类号 A61P35/00;A61K31/4545;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P29/00;A61P43/00 主分类号 A61P35/00
代理机构 代理人
主权项
地址